New York Approved Proactive

Proactive genetic testing offers healthy adults without a strong personal or family history of disease an opportunity to learn about how their genes could potentially impact their health.

Invitae offers testing options that analyze genes that are well-established indicators of a significantly increased risk of developing hereditary cancers, cardiovascular conditions, and other medically important disorders. Learn more

Invitae is a New York state approved clinical laboratory. The tests and genes on this page are approved or under conditional approval by New York State to be performed at Invitae and do not require a New York exemption form.

167 genes

Invitae Genetic Health Screen

Learn More

Analyzes genes associated with hereditary conditions that, if detected early, may have effective medical interventions and preventive measures.

65 genes

Invitae Cancer Screen

Learn More

Analyzes genes associated with hereditary cancer susceptibility conditions that, if detected early, may have effective medical interventions and preventive measures.

83 genes

Invitae Cardio Screen

Learn More

Analyzes genes associated with hereditary cardiovascular conditions that, if detected early, may have effective medical interventions and preventive measures.

8 genes

Invitae Surgical Risk Screen

Learn More

Analyzes genes associated with conditions that may have surgery-related clinical implications.

11 genes

Invitae First Tier Population Screen

Learn More

Analyzes genes that have the potential to improve public health, as defined by the Centers for Disease Control and Prevention’s (CDC’s) Office of Public Health Genomics (OPHG).

81 genes

Invitae 81 Gene Actionable Disorders Panel

Learn More

Analyzes genes identified as medically actionable by the American College of Medical Genetics and Genomics.

16 genes

Invitae eMERGE Panel

Learn More

Analyzes genes selected by The Electronic Medical Records and Genomics (eMERGE) Genomic Risk Assessment and Management Network.